MAPT and Alzheimer disease: In this study, we defined the community-useful thresholds for plasma Aβ42/Aβ40 and p-Tau181 and evaluated their feasibility in identifying individuals with a high risk of AD based on Aβ PET, tau PET, and MRI image data in a large community-based Chinese aging cohort.